SCHEMBL30168596

SCHEMBL30168596

CO/C=C(\Oc1cc(/C(C)=N/OC(C)C)ccc1C)C(=O)OC

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.38
NPY1R P25929 1/20 0.38
NPY2R P49146 1/20 0.38
PPARG P37231 2/20 0.35
PPARA Q07869 2/20 0.35
NOTUM Q6P988 1/20 0.34
TAS1R3 Q7RTX0 2/20 0.33
TAS1R1 Q7RTX1 2/20 0.33
ALDH1A1 P00352 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
TMPRSS15 P98073 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
PDE4B Q07343 1/20 0.31
PDE4D Q08499 1/20 0.31
MAPK14 Q16539 1/20 0.31
ACHE P22303 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8026099 0.85 NOTUM (0.37) MAPTPPARGPPARANOTUMTAS1R3
SCHEMBL8026096 0.85 NOTUM (0.37) MAPTPPARGPPARANOTUMTAS1R3
SCHEMBL21647869 0.85 NOTUM (0.37) MAPTPPARGPPARANOTUMTAS1R3
SCHEMBL21675874 0.85 NOTUM (0.37) MAPTPPARGPPARANOTUMTAS1R3
SCHEMBL26418271 0.85 NOTUM (0.37) MAPTPPARGPPARANOTUMTAS1R3
SCHEMBL8026643 0.82 NOTUM (0.40) MAPTNOTUMTAS1R3TAS1R1ALDH1A1
SCHEMBL8026645 0.82 NOTUM (0.40) MAPTNOTUMTAS1R3TAS1R1ALDH1A1
SCHEMBL8020365 0.81 PPARG (0.39) MAPTPPARGPPARANOTUMALDH1A1
SCHEMBL8023016 0.81 PPARG (0.39) MAPTPPARGPPARANOTUMALDH1A1
SCHEMBL8020369 0.81 PPARG (0.39) MAPTPPARGPPARANOTUMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12520843-B2 Plant disease control composition and plant disease control method SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2026-01-13 US claimed
US-20230130546-A1 PLANT DISEASE CONTROL COMPOSITION AND PLANT DISEASE CONTROL METHOD SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-04-27 US claimed
US-20230100754-A1 PLANT DISEASE CONTROL COMPOSITION AND PLANT DISEASE CONTROL METHOD SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-03-30 US claimed
US-20230069915-A1 PLANT DISEASE CONTROL COMPOSITION AND PLANT DISEASE CONTROL METHOD SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-03-09 US claimed
US-12520843-B2 Plant disease control composition and plant disease control method SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2026-01-13 US disclosed
US-20230130546-A1 PLANT DISEASE CONTROL COMPOSITION AND PLANT DISEASE CONTROL METHOD SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-04-27 US disclosed
US-20230100754-A1 PLANT DISEASE CONTROL COMPOSITION AND PLANT DISEASE CONTROL METHOD SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-03-30 US disclosed
US-20230069915-A1 PLANT DISEASE CONTROL COMPOSITION AND PLANT DISEASE CONTROL METHOD SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-03-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230069915-A1 PLANT DISEASE CONTROL COMPOSITION AND PLANT DISEASE CONTROL METHOD MT-CO3, MT-CO2, HADHB MAPT 3412/4885NPY1R 4731/4885NPY2R 4631/4885
US-20230130546-A1 PLANT DISEASE CONTROL COMPOSITION AND PLANT DISEASE CONTROL METHOD FASTKD1, MT-CO1, MT-CO2 MAPT 465/4885NPY1R 1159/4885NPY2R 1149/4885
US-20230100754-A1 PLANT DISEASE CONTROL COMPOSITION AND PLANT DISEASE CONTROL METHOD CYP51A1, CTRL, ERG28 MAPT 1024/4885NPY1R 4811/4885NPY2R 4834/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.